BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9890024)

  • 21. Efficiency and safety of an inactivated feline parvovirus vaccine against canine parvovirus infection.
    Chapek ML; McClaughry LE; Wilkins LM
    Mod Vet Pract; 1980 Mar; 61(3):261-3. PubMed ID: 7366579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
    Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
    Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parvovirus infections in dogs and cats: problems of immunization].
    Mayr A
    Tierarztl Prax; 1989; 17(4):399-402. PubMed ID: 2559494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compatibility between a rabies vaccine and two canine combined vaccines against canine distemper, adenovirosis, parvovirosis, parainfluenza virus disease and leptospirosis, with or without canine coronavirus.
    Thibault JC; Bouvet J; Cupillard L; Cariou C; Oberli F
    Comp Immunol Microbiol Infect Dis; 2022 Jul; 86():101803. PubMed ID: 35429805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canine and feline immunization.
    Schultz RD; Scott FW
    Vet Clin North Am; 1978 Nov; 8(4):755-68. PubMed ID: 220773
    [No Abstract]   [Full Text] [Related]  

  • 28. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine.
    Krakowka S; Olsen RG; Axthelm MK; Rice J; Winters K
    J Am Vet Med Assoc; 1982 Jan; 180(2):137-9. PubMed ID: 7061309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
    Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
    Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against canine parvovirus disease.
    Folkers C; Wilson JH; Roerink JH; Hermann-Dekkers WM
    Vet Rec; 1982 Mar; 110(10):235. PubMed ID: 7080409
    [No Abstract]   [Full Text] [Related]  

  • 33. CANINE DISTEMPER AND PARVOVIRUS VACCINATION WITH RECOMBITEK C3 IN AFRICAN WILD DOGS (
    Mulreany LM; Cushing AC; Ramsay EC
    J Zoo Wildl Med; 2021 Dec; 52(4):1229-1233. PubMed ID: 34998293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of greyhounds against canine parvovirus.
    Prole JH
    Vet Rec; 1980 Jan; 106(4):88. PubMed ID: 7355563
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination at different anatomic sites induces different levels of the immune responses.
    Jin H; Xu Y; Shi F; Hu S
    Res Vet Sci; 2019 Feb; 122():50-55. PubMed ID: 30453180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Neutralizing Antibodies to Canine Distemper Virus and Response to Vaccination in Client-Owned Adult Healthy Dogs.
    Bergmann M; Freisl M; Zablotski Y; Khan MAA; Speck S; Truyen U; Hartmann K
    Viruses; 2021 May; 13(5):. PubMed ID: 34065493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination against canine parvovirus.
    Vet Rec; 1979 Dec; 105(24):560. PubMed ID: 532070
    [No Abstract]   [Full Text] [Related]  

  • 38. Canine parvovirus infection, canine distemper and infectious canine hepatitis: inclination to vaccinate and antibody response in the Swedish dog population.
    Olson P; Hedhammar A; Klingeborn B
    Acta Vet Scand; 1996; 37(4):433-43. PubMed ID: 9050276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of immunity against canine distemper, adenovirus and parvovirus after vaccination with two multivalent canine vaccines.
    Cunha RDS; da Silva Junior CL; Costa CA; de Aguiar HM; Junqueira Júnior DG
    Vet Med Sci; 2020 Aug; 6(3):330-334. PubMed ID: 32338828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.